title: [Avascular osteonecrosis of the jaws induced by diphosphonates].
authors.forename: Damien
authors.initials: D
authors.lastname: Lannoy
authors.forename: Bertrand
authors.initials: B
authors.lastname: Decaudin
authors.forename: Frédérique
authors.initials: F
authors.lastname: Barrier
authors.forename: Maxime
authors.initials: M
authors.lastname: Bemba
authors.forename: Laurence
authors.initials: L
authors.lastname: Wierre
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pignon
authors.forename: Sandrine
authors.initials: S
authors.lastname: Horrent
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Résibois
authors.forename: Marc
authors.initials: M
authors.lastname: Wetterwald
authors.forename: Pascal
authors.initials: P
authors.lastname: Odou
mesh_terms: D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007571:Jaw Diseases / Q000139:chemically induced*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications; D010020:Osteonecrosis / Q000139:chemically induced*; D010954:Plasmacytoma / Q000150:complications; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid